N. Pal

Effectiveness of PD-(L)1 Inhibitors Alone or in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Non-Squamous Non-Small Cell Lung Cancer (nsq-NSCLC) With PD-L1-High Expression Using Real-World Data.

U. Dafni, R. Stahel, E. Felip, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.

J. Cowell, R. Wadey, J. Pritchard, 1990, Oncogene.

Citation: Deepak Nathiya et al. Predictors of Health-Related Quality of Life in Sacropenic Patients: Result from BCAAS

N. Pal, R. Rai, Preeti Raj, 2021 .

Detection of Non-Alcoholic Fatty Liver Disease in Patients with Type-2 Diabetes Mellitus

N. Pal, Ashu Yadav, G. Devpura, 2022, East African Scholars Journal of Medical Sciences.

Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 153,122 U.S. patients

S. Rizzo, S. Waliany, J. Zou, 2023, medRxiv.

Preferential loss of maternal alleles in sporadic Wilms' tumour.

J. Cowell, R. Wadey, J. Pritchard, 1990, Oncogene.

Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study

Mahaveer Singh, N. Pal, B. Tomar, 2022, Frontiers in Endocrinology.

VP2-2021: Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small cell lung cancer (Nsq-NSCLC) with high PD-L1 expression using real-world data

U. Dafni, R. Stahel, S. Peters, 2021 .